Abigail Smith is a Senior Advisor in Medicinal Chemistry at Eli Lilly and Company, specializing in synthetic organic chemistry and complex molecule synthesis. Previously, they served as a Graduate Research Assistant at Vanderbilt University, where they led a collaborative drug-discovery effort and contributed to significant research on macrocyclocoligomerization reactions. Abigail's early experience includes working as an Undergraduate Research Assistant at the University of Evansville, focusing on the development of a “smart” therapeutic prototype for cancer chemotherapy. Throughout their career, Abigail has demonstrated a strong commitment to advancing therapeutic design and has presented research at various national conferences.
Location
Indianapolis, United States